UPDATE: Needham & Company Upgrades Acadia Pharmaceuticals (ACAD) to Buy, $9 Price Target
Go back to UPDATE: Needham & Company Upgrades Acadia Pharmaceuticals (ACAD) to Buy, $9 Price Target| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 29.50 +0.46 (1.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.04 | 52 Week High | $42.49 | |||
| Open | $29.08 | 52 Week Low | $16.64 | |||
| Day High | $29.62 | P/E | N/A | |||
| Day Low | $28.80 | EPS | $-0.42 | |||
| Volume | 1,093,511 | |||||
